Cyclo[Dip-Tza-Leu-D-N(Me)Val-D-Leu] forms a conformationally locked macrocycle containing noncanonical residues and N-methylation. Such features restrict backbone motion and enhance resistance to proteolysis. Researchers probe its interaction with hydrophobic pockets and structured protein surfaces. Applications include cyclic-peptidomimetic design, ligand-scaffold optimization, and stability-focused structure-activity studies.
Cyclo[Dip-Tza-Leu-D-N(Me)Val-D-Leu] is a synthetic cyclic peptide featuring a unique sequence that incorporates non-standard amino acid residues such as Dip-Tza and N-methylated valine. Its macrocyclic structure imparts conformational rigidity and enhanced stability compared to linear peptides, making it an attractive scaffold for probing peptide structure-activity relationships and for applications in advanced biochemical research. The inclusion of both D-amino acids and N-methylated residues further augments its resistance to enzymatic degradation, expanding its utility in experimental settings that demand robust peptide constructs. As a chemically defined cyclic peptide, it serves as a valuable tool for researchers investigating the functional consequences of cyclization, backbone modifications, and sequence diversity within peptide-based systems.
Peptide structure-activity relationship studies: The distinctive sequence and cyclized backbone of this peptide make it a powerful probe in studies aimed at elucidating the impact of macrocyclization and side-chain modifications on biological activity. Researchers can use it to systematically assess how conformational constraints influence receptor binding, molecular recognition, or enzymatic susceptibility, providing insights that inform the rational design of next-generation peptide ligands or inhibitors.
Enzyme stability and proteolytic resistance assays: Due to its incorporation of D-amino acids and N-methylated residues, the compound is highly resistant to proteolytic cleavage. It is well-suited for use as a reference or control substrate in assays evaluating the stability of peptides against various proteases. Such studies are critical for the development of peptide therapeutics, diagnostics, or biomaterials that require extended in vitro or in vivo stability.
Peptide synthesis and analytical method development: The complex structure of cyclo[Dip-Tza-Leu-D-N(Me)Val-D-Leu] makes it an excellent test substrate for advancing synthetic methodologies and analytical techniques in peptide chemistry. It can be employed to challenge and optimize solid-phase peptide synthesis protocols, cyclization strategies, and purification workflows. Additionally, it serves as a benchmark for validating chromatographic and spectrometric methods, particularly those aimed at characterizing macrocyclic and non-canonical peptide architectures.
Molecular modeling and conformational analysis: The macrocyclic topology and inclusion of both D- and N-methylated amino acids provide a rich template for computational studies. Researchers can utilize this peptide in molecular dynamics simulations and structure prediction algorithms to explore how backbone modifications influence folding, rigidity, and surface presentation. Such analyses are essential for understanding the biophysical properties of cyclic peptides and for guiding the design of molecules with tailored conformational profiles.
Ligand discovery and screening platforms: Owing to its stable and conformationally restricted scaffold, this cyclic peptide is a valuable component in high-throughput screening libraries targeting protein-protein interactions or other biomolecular interfaces. Its unique sequence diversity and resistance to degradation enable its use in the identification of novel binding motifs, facilitating the discovery of peptide ligands with enhanced affinity, selectivity, or functional resilience in complex biological environments.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.